- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
According to our latest study, the global Levoamlodipine market size was valued at USD 36630 million in 2022 and is forecast to a readjusted size of USD 75160 million by 2029 with a CAGR of 10.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
Levoamlodipine can effectively control 24-hour blood pressure, especially at night blood pressure control has unique advantages, it can also effectively prevent the sudden rise of blood pressure in the morning, reduce the sharp rise and fall of blood pressure, so as to effectively maintain the blood flow of important organs and protect the function of target organs.
This report is a detailed and comprehensive analysis for global Levoamlodipine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Levoamlodipine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Levoamlodipine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Levoamlodipine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Levoamlodipine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Levoamlodipine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Levoamlodipine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aristo Pharmaceuticals Pvt Ltd, Novartis, Pfizer, Lek and TEVA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Levoamlodipine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Amlodipine Besylate Tablets
Amlodipine Mesylate Tablets
Amlodipine Maleate Tablets
Market segment by Application
Hypertension
Angina pectoris
Major players covered
Aristo Pharmaceuticals Pvt Ltd
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Chengdu Di'ao Pharmaceutical Group Co., Ltd.
Yangzijiang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Levoamlodipine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Levoamlodipine, with price, sales, revenue and global market share of Levoamlodipine from 2018 to 2023.
Chapter 3, the Levoamlodipine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Levoamlodipine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Levoamlodipine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Levoamlodipine.
Chapter 14 and 15, to describe Levoamlodipine sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Levoamlodipine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Levoamlodipine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Amlodipine Besylate Tablets
1.3.3 Amlodipine Mesylate Tablets
1.3.4 Amlodipine Maleate Tablets
1.4 Market Analysis by Application
1.4.1 Overview: Global Levoamlodipine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hypertension
1.4.3 Angina pectoris
1.5 Global Levoamlodipine Market Size & Forecast
1.5.1 Global Levoamlodipine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Levoamlodipine Sales Quantity (2018-2029)
1.5.3 Global Levoamlodipine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Aristo Pharmaceuticals Pvt Ltd
2.1.1 Aristo Pharmaceuticals Pvt Ltd Details
2.1.2 Aristo Pharmaceuticals Pvt Ltd Major Business
2.1.3 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Product and Services
2.1.4 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Levoamlodipine Product and Services
2.2.4 Novartis Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Levoamlodipine Product and Services
2.3.4 Pfizer Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Lek
2.4.1 Lek Details
2.4.2 Lek Major Business
2.4.3 Lek Levoamlodipine Product and Services
2.4.4 Lek Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lek Recent Developments/Updates
2.5 TEVA
2.5.1 TEVA Details
2.5.2 TEVA Major Business
2.5.3 TEVA Levoamlodipine Product and Services
2.5.4 TEVA Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 TEVA Recent Developments/Updates
2.6 Macleods Pharmaceuticals
2.6.1 Macleods Pharmaceuticals Details
2.6.2 Macleods Pharmaceuticals Major Business
2.6.3 Macleods Pharmaceuticals Levoamlodipine Product and Services
2.6.4 Macleods Pharmaceuticals Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Macleods Pharmaceuticals Recent Developments/Updates
2.7 Caraco Pharmaceutical
2.7.1 Caraco Pharmaceutical Details
2.7.2 Caraco Pharmaceutical Major Business
2.7.3 Caraco Pharmaceutical Levoamlodipine Product and Services
2.7.4 Caraco Pharmaceutical Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Caraco Pharmaceutical Recent Developments/Updates
2.8 Sanis Health
2.8.1 Sanis Health Details
2.8.2 Sanis Health Major Business
2.8.3 Sanis Health Levoamlodipine Product and Services
2.8.4 Sanis Health Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sanis Health Recent Developments/Updates
2.9 Jamp Pharma
2.9.1 Jamp Pharma Details
2.9.2 Jamp Pharma Major Business
2.9.3 Jamp Pharma Levoamlodipine Product and Services
2.9.4 Jamp Pharma Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Jamp Pharma Recent Developments/Updates
2.10 Accel Pharma
2.10.1 Accel Pharma Details
2.10.2 Accel Pharma Major Business
2.10.3 Accel Pharma Levoamlodipine Product and Services
2.10.4 Accel Pharma Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Accel Pharma Recent Developments/Updates
2.11 Jubilant Generics
2.11.1 Jubilant Generics Details
2.11.2 Jubilant Generics Major Business
2.11.3 Jubilant Generics Levoamlodipine Product and Services
2.11.4 Jubilant Generics Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Jubilant Generics Recent Developments/Updates
2.12 Angita Pharma
2.12.1 Angita Pharma Details
2.12.2 Angita Pharma Major Business
2.12.3 Angita Pharma Levoamlodipine Product and Services
2.12.4 Angita Pharma Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Angita Pharma Recent Developments/Updates
2.13 Florida DOH Central Pharmacy
2.13.1 Florida DOH Central Pharmacy Details
2.13.2 Florida DOH Central Pharmacy Major Business
2.13.3 Florida DOH Central Pharmacy Levoamlodipine Product and Services
2.13.4 Florida DOH Central Pharmacy Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Florida DOH Central Pharmacy Recent Developments/Updates
2.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
2.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Details
2.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Major Business
2.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Product and Services
2.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
2.15 Yangzijiang Pharmaceutical
2.15.1 Yangzijiang Pharmaceutical Details
2.15.2 Yangzijiang Pharmaceutical Major Business
2.15.3 Yangzijiang Pharmaceutical Levoamlodipine Product and Services
2.15.4 Yangzijiang Pharmaceutical Levoamlodipine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Yangzijiang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Levoamlodipine by Manufacturer
3.1 Global Levoamlodipine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Levoamlodipine Revenue by Manufacturer (2018-2023)
3.3 Global Levoamlodipine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Levoamlodipine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Levoamlodipine Manufacturer Market Share in 2022
3.4.2 Top 6 Levoamlodipine Manufacturer Market Share in 2022
3.5 Levoamlodipine Market: Overall Company Footprint Analysis
3.5.1 Levoamlodipine Market: Region Footprint
3.5.2 Levoamlodipine Market: Company Product Type Footprint
3.5.3 Levoamlodipine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Levoamlodipine Market Size by Region
4.1.1 Global Levoamlodipine Sales Quantity by Region (2018-2029)
4.1.2 Global Levoamlodipine Consumption Value by Region (2018-2029)
4.1.3 Global Levoamlodipine Average Price by Region (2018-2029)
4.2 North America Levoamlodipine Consumption Value (2018-2029)
4.3 Europe Levoamlodipine Consumption Value (2018-2029)
4.4 Asia-Pacific Levoamlodipine Consumption Value (2018-2029)
4.5 South America Levoamlodipine Consumption Value (2018-2029)
4.6 Middle East and Africa Levoamlodipine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Levoamlodipine Sales Quantity by Type (2018-2029)
5.2 Global Levoamlodipine Consumption Value by Type (2018-2029)
5.3 Global Levoamlodipine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Levoamlodipine Sales Quantity by Application (2018-2029)
6.2 Global Levoamlodipine Consumption Value by Application (2018-2029)
6.3 Global Levoamlodipine Average Price by Application (2018-2029)
7 North America
7.1 North America Levoamlodipine Sales Quantity by Type (2018-2029)
7.2 North America Levoamlodipine Sales Quantity by Application (2018-2029)
7.3 North America Levoamlodipine Market Size by Country
7.3.1 North America Levoamlodipine Sales Quantity by Country (2018-2029)
7.3.2 North America Levoamlodipine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Levoamlodipine Sales Quantity by Type (2018-2029)
8.2 Europe Levoamlodipine Sales Quantity by Application (2018-2029)
8.3 Europe Levoamlodipine Market Size by Country
8.3.1 Europe Levoamlodipine Sales Quantity by Country (2018-2029)
8.3.2 Europe Levoamlodipine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Levoamlodipine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Levoamlodipine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Levoamlodipine Market Size by Region
9.3.1 Asia-Pacific Levoamlodipine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Levoamlodipine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Levoamlodipine Sales Quantity by Type (2018-2029)
10.2 South America Levoamlodipine Sales Quantity by Application (2018-2029)
10.3 South America Levoamlodipine Market Size by Country
10.3.1 South America Levoamlodipine Sales Quantity by Country (2018-2029)
10.3.2 South America Levoamlodipine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Levoamlodipine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Levoamlodipine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Levoamlodipine Market Size by Country
11.3.1 Middle East & Africa Levoamlodipine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Levoamlodipine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Levoamlodipine Market Drivers
12.2 Levoamlodipine Market Restraints
12.3 Levoamlodipine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Levoamlodipine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Levoamlodipine
13.3 Levoamlodipine Production Process
13.4 Levoamlodipine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Levoamlodipine Typical Distributors
14.3 Levoamlodipine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Levoamlodipine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Levoamlodipine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Aristo Pharmaceuticals Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Aristo Pharmaceuticals Pvt Ltd Major Business
Table 5. Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Product and Services
Table 6. Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Major Business
Table 10. Novartis Levoamlodipine Product and Services
Table 11. Novartis Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novartis Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Levoamlodipine Product and Services
Table 16. Pfizer Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Lek Basic Information, Manufacturing Base and Competitors
Table 19. Lek Major Business
Table 20. Lek Levoamlodipine Product and Services
Table 21. Lek Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lek Recent Developments/Updates
Table 23. TEVA Basic Information, Manufacturing Base and Competitors
Table 24. TEVA Major Business
Table 25. TEVA Levoamlodipine Product and Services
Table 26. TEVA Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. TEVA Recent Developments/Updates
Table 28. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Macleods Pharmaceuticals Major Business
Table 30. Macleods Pharmaceuticals Levoamlodipine Product and Services
Table 31. Macleods Pharmaceuticals Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Macleods Pharmaceuticals Recent Developments/Updates
Table 33. Caraco Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Caraco Pharmaceutical Major Business
Table 35. Caraco Pharmaceutical Levoamlodipine Product and Services
Table 36. Caraco Pharmaceutical Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Caraco Pharmaceutical Recent Developments/Updates
Table 38. Sanis Health Basic Information, Manufacturing Base and Competitors
Table 39. Sanis Health Major Business
Table 40. Sanis Health Levoamlodipine Product and Services
Table 41. Sanis Health Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sanis Health Recent Developments/Updates
Table 43. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Jamp Pharma Major Business
Table 45. Jamp Pharma Levoamlodipine Product and Services
Table 46. Jamp Pharma Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Jamp Pharma Recent Developments/Updates
Table 48. Accel Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Accel Pharma Major Business
Table 50. Accel Pharma Levoamlodipine Product and Services
Table 51. Accel Pharma Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Accel Pharma Recent Developments/Updates
Table 53. Jubilant Generics Basic Information, Manufacturing Base and Competitors
Table 54. Jubilant Generics Major Business
Table 55. Jubilant Generics Levoamlodipine Product and Services
Table 56. Jubilant Generics Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Jubilant Generics Recent Developments/Updates
Table 58. Angita Pharma Basic Information, Manufacturing Base and Competitors
Table 59. Angita Pharma Major Business
Table 60. Angita Pharma Levoamlodipine Product and Services
Table 61. Angita Pharma Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Angita Pharma Recent Developments/Updates
Table 63. Florida DOH Central Pharmacy Basic Information, Manufacturing Base and Competitors
Table 64. Florida DOH Central Pharmacy Major Business
Table 65. Florida DOH Central Pharmacy Levoamlodipine Product and Services
Table 66. Florida DOH Central Pharmacy Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Florida DOH Central Pharmacy Recent Developments/Updates
Table 68. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Major Business
Table 70. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Product and Services
Table 71. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 73. Yangzijiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Yangzijiang Pharmaceutical Major Business
Table 75. Yangzijiang Pharmaceutical Levoamlodipine Product and Services
Table 76. Yangzijiang Pharmaceutical Levoamlodipine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Yangzijiang Pharmaceutical Recent Developments/Updates
Table 78. Global Levoamlodipine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Levoamlodipine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Levoamlodipine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Levoamlodipine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Levoamlodipine Production Site of Key Manufacturer
Table 83. Levoamlodipine Market: Company Product Type Footprint
Table 84. Levoamlodipine Market: Company Product Application Footprint
Table 85. Levoamlodipine New Market Entrants and Barriers to Market Entry
Table 86. Levoamlodipine Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Levoamlodipine Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Levoamlodipine Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Levoamlodipine Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Levoamlodipine Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Levoamlodipine Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Levoamlodipine Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Levoamlodipine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Levoamlodipine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Levoamlodipine Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Levoamlodipine Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Levoamlodipine Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Levoamlodipine Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Levoamlodipine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Levoamlodipine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Levoamlodipine Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Levoamlodipine Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Levoamlodipine Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Levoamlodipine Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Levoamlodipine Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Levoamlodipine Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Levoamlodipine Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Levoamlodipine Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Levoamlodipine Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Levoamlodipine Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Levoamlodipine Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Levoamlodipine Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Levoamlodipine Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Levoamlodipine Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Levoamlodipine Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Levoamlodipine Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Levoamlodipine Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Levoamlodipine Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Levoamlodipine Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Levoamlodipine Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Levoamlodipine Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Levoamlodipine Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Levoamlodipine Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Levoamlodipine Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Levoamlodipine Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Levoamlodipine Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Levoamlodipine Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Levoamlodipine Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Levoamlodipine Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Levoamlodipine Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Levoamlodipine Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Levoamlodipine Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Levoamlodipine Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Levoamlodipine Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Levoamlodipine Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Levoamlodipine Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Levoamlodipine Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Levoamlodipine Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Levoamlodipine Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Levoamlodipine Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Levoamlodipine Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Levoamlodipine Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Levoamlodipine Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Levoamlodipine Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Levoamlodipine Raw Material
Table 146. Key Manufacturers of Levoamlodipine Raw Materials
Table 147. Levoamlodipine Typical Distributors
Table 148. Levoamlodipine Typical Customers
List of Figures
Figure 1. Levoamlodipine Picture
Figure 2. Global Levoamlodipine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Levoamlodipine Consumption Value Market Share by Type in 2022
Figure 4. Amlodipine Besylate Tablets Examples
Figure 5. Amlodipine Mesylate Tablets Examples
Figure 6. Amlodipine Maleate Tablets Examples
Figure 7. Global Levoamlodipine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Levoamlodipine Consumption Value Market Share by Application in 2022
Figure 9. Hypertension Examples
Figure 10. Angina pectoris Examples
Figure 11. Global Levoamlodipine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Levoamlodipine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Levoamlodipine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Levoamlodipine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Levoamlodipine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Levoamlodipine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Levoamlodipine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Levoamlodipine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Levoamlodipine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Levoamlodipine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Levoamlodipine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Levoamlodipine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Levoamlodipine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Levoamlodipine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Levoamlodipine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Levoamlodipine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Levoamlodipine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Levoamlodipine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Levoamlodipine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Levoamlodipine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Levoamlodipine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Levoamlodipine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Levoamlodipine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Levoamlodipine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Levoamlodipine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Levoamlodipine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Levoamlodipine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Levoamlodipine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Levoamlodipine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Levoamlodipine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Levoamlodipine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Levoamlodipine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Levoamlodipine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Levoamlodipine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Levoamlodipine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Levoamlodipine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Levoamlodipine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Levoamlodipine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Levoamlodipine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Levoamlodipine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Levoamlodipine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Levoamlodipine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Levoamlodipine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Levoamlodipine Market Drivers
Figure 74. Levoamlodipine Market Restraints
Figure 75. Levoamlodipine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Levoamlodipine in 2022
Figure 78. Manufacturing Process Analysis of Levoamlodipine
Figure 79. Levoamlodipine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
